Evidence map›Paper›PMID 24062373›Full record

ReviewPediatrics2013

Trends in invasive methicillin-resistant Staphylococcus aureus infections.

Martha Iwamoto, Yi Mu, Ruth Lynfield, Sandra N Bulens, Joelle Nadle, Deborah Aragon, Susan Petit, Susan M Ray, Lee H Harrison, Ghinwa Dumyati and 4 more

Registry-linked trialAbstract readCase ReportsReview
In one paragraph

Review in Pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04911270 (A Pharmacokinetic Study to Evaluate the Use of a Novel Clinical Decision Support Tool, Lyv, in Achieving AUC24/MIC > 400 in Pediatric Patients on Vancomycin), which is not on this map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04911270 nacompletednot on this mapstarted 2022, after this paper: background citation

A Pharmacokinetic Study to Evaluate the Use of a Novel Clinical Decision Support Tool, Lyv, in Achieving AUC24/MIC > 400 in Pediatric Patients on Vancomycin

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2022 to 2025Enrolled75ConditionsGram-Positive Bacterial Infections, Vancomycin, Pharmacokinetics, PharmacodynamicsArmsComputer Decision Support Tool Intervention Group, Matched Historical Controls
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Open forum infectious diseases · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Management and Prevention of Staphylococcus aureus Infections in Children.Infectious disease clinics of North America · 2022
    Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 1 country.

Martha IwamotoCenters for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop C-09, Atlanta, GA 30333. miwamoto@cdc.gov.
Yi Mu
Ruth Lynfield
Sandra N Bulens
Joelle Nadle
Deborah Aragon
Susan Petit
Susan M Ray
Lee H Harrison
Ghinwa Dumyati
John M Townes
William Schaffner
Rachel J Gorwitz
Fernanda C Lessa
Centers for Disease Control and Prevention · USColorado Department of Public Health and Environment · USEmory University · USHartford Financial Services (United States)Maryland Department of Health · USMinnesota Department of Health · USOregon Health & Science University · USUniversity of Rochester · USVanderbilt University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectiveTo describe trends in the incidence of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in children during 2005-2010.

methodsWe evaluated reports of invasive MRSA infections in pediatric patients identified from population-based surveillance during 2005-2010. Cases were defined as isolation of MRSA from a normally sterile site and classified on the basis of the setting of the positive culture and presence or absence of health care exposures. Estimated annual changes in incidence were determined by using regression models. National age- and race-specific incidences for 2010 were estimated by using US census data.

resultsA total of 876 pediatric cases were reported; 340 (39%) were among infants. Overall, 35% of cases were hospital-onset, 23% were health care-associated community-onset, and 42% were community-associated (CA). The incidence of invasive CA-MRSA infection per 100000 children increased from 1.1 in 2005 to 1.7 in 2010 (modeled yearly increase: 10.2%; 95% confidence interval: 2.7%-18.2%). No significant trends were observed for health care-associated community-onset and hospital-onset cases. Nationally, estimated invasive MRSA incidence in 2010 was higher among infants aged <90 days compared with older infants and children (43.9 vs 2.0 per 100000) and among black children compared with other races (6.7 vs 1.6 per 100000).

conclusionsInvasive MRSA infection in children disproportionately affects young infants and black children. In contrast to reports of declining incidence among adults, there were no significant reductions in health care-associated MRSA infections in children. Concurrently, the incidence of CA-MRSA infections has increased, underscoring the need for defining optimal strategies to prevent MRSA infections among children with and without health care exposures.

Indexed as

Methicillin ResistancePopulation SurveillanceAdolescentAge FactorsBlack PeopleChildChild, PreschoolFemaleHumansIncidenceInfantInfant, NewbornMaleMethicillin-Resistant Staphylococcus aureusStaphylococcal Infectionschildrenepidemiologyinfantsmethicillin resistanceStaphylococcus aureus infection

Identifiers

PMID24062373
PMCPMC11931424
OpenAlexW2111694921

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.